Navigation Links
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Date:6/23/2011

reak down large chylomicron molecules, the accumulation of which, after intake of dietary fat, seems to be responsible for the occurrence of pancreatitis in LPLD patients. AMT is initiating study CT-AMT-011-04 to examine further how already treated patients handle chylomicrons over time. In addition, AMT will continue to collect follow up data on pancreatitis incidence. AMT's available funds will support its existing operations beyond the completion of the re-examination process into 2012.

"Based on communication from EMA, we understand that our technology platform using adeno-associated virus (AAV) vectors is approvable," Mr. Aldag added. "While we pursue the re-examination of Glybera, we will also continue development of other products in our pipeline such as hemophilia B and GDNF gene therapy for Parkinson's disease and Huntington's disease. We will also continue our preparations for registrations in Canada and the US."

For investors, AMT will conduct a conference call at 9:00 AM CET on June 24, 2011. To participate in the conference call, please call one of the following telephone numbers 15 minutes prior to the event, using access code 2788745: +44-(0)20-7136-2054 for the UK; +1-718-247-0881 for the US; and + 31-(0)20-201-5468 for the Netherlands. A pdf version of the presentation is available in the news and investor relations sections of the corporate website. Following the presentation, the lines will be opened for a question and answer session. A replay of the call will be available following the event.

About Glybera

AMT has developed Glybera as a treatment for patients with the genetic disorder lipoprotein lipase deficiency. LPLD is an orphan disease for which no treatment exists today. The disease is caused by mutations in the LPL gene, resulting in highly decreased or absent activity of LPL protein in patients. This protein is needed in order to break down large fat-carrying particles that circ
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharma and Food Thought Leaders Set to Converge in Amsterdam Next April 2011
2. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
3. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
4. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
5. Data from Clinical Studies of bioTheranostics CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
6. ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
7. Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia
8. The World Leader in Molecular Breast Imaging to Premiere Largest Detector in the Industry
9. Gen-Probe Files for US Regulatory Clearance of PANTHER™ System, Fully Automated and Integrated Molecular Testing Instrument
10. Latest Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging (MBI)
11. Cepheid Extends Rapid Molecular Diagnostics Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... Va. and WASHINGTON , ... Specialty Pharmacy (NASP) and SmartBrief recently partnered to deliver ... a snapshot of the top news in the industry. ... pharmacies, pharmaceutical and biotechnology manufacturers, GPOs, distributors and other ... resource will launch on April 27, 2015. ...
(Date:4/27/2015)... , April 27, 2015 Demonstrating the power ... announced that LifeScience Alley  will produce a world ... MD&M Minneapolis event, November 4-5, 2015, at the ... Minneapolis, MN. This combined 2015 Minneapolis ... manufacturers, suppliers, and business leaders all under one roof, ...
(Date:4/27/2015)... 2015 PAML announced today that the ... Axela, Inc. to develop multiplex assays focused on ... of the nation,s leading medical reference laboratories, and ... analysis for clinical diagnostics. Axela,s ... assay development serves as the foundation for novel ...
Breaking Medicine Technology:NASP and SmartBrief Partner on Specialty Pharmacy SmartBrief 2LifeScience Alley and MD&M Minneapolis partner for Minnesota Medtech Week 2LifeScience Alley and MD&M Minneapolis partner for Minnesota Medtech Week 3PAML and Axela Collaborate on Immune Status for Vaccine Preventable Diseases 2
... -- The Six-Month Primary Efficacy Endpoint ... Significantly Increased "ON" Time in,Levodopa-Treated Patients With mid- to Late-Stage ... Endpoints of the Study Analyzed to Date Were met in,Both ... a division of Merck KGaA, Darmstadt, Germany, and its,partner Newron ...
... NEW YORK, Feb. 2 A study led by ... has identified a gene associated with the development of ... With funding provided by the Dystonia Medical Research Foundation ... mutations in the THAP1 gene cause DYT6 dystonia in ...
Cached Medicine Technology:Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial 2Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial 3Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial 4Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial 5Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial 6Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder 2
(Date:4/27/2015)... 27, 2015 Array Health , ... has announced that Lance Hood, senior director of marketing, ... annual Direct-to-Consumer Health Care Marketing Summit on ... Smith, Partner and Director of Payer Services, Leavitt Partners, ... consumerism – through a retail/e-commerce perspective – and equip ...
(Date:4/27/2015)... 27, 2015 Beckman Coulter is sponsoring ... to study the evolution of neural circuitry and swimming ... review the mechanisms by which analogous forms of swimming ... flexions, evolved independently in certain sea slug clades. The ... live April 30, 2015 at 8:00am PT. , Sea ...
(Date:4/27/2015)... Los Angeles, CA (PRWEB) April 27, 2015 ... years has been to connect clients of personal injury attorneys ... The network of doctors has seen steady growth throughout their ... Dr. Charles E. Richardson, DC and his team in ... team including a medical doctor and massage therapist, patients can ...
(Date:4/27/2015)... Guided by the extensive work of its community ... collaboration with organizations around the world to identify proven ... essential actions for organizations committed to patient experience ... systems committed to providing the best in experience will:, ... with committed time and focused intent to shape and ...
(Date:4/27/2015)... 27, 2015 Douglas Fitzpatrick not ... clients feel secure, but also helps secure homes for animals. ... Douglas will be manning a booth at the 2015 Fetch ... 717 E. 17th Ave., Columbus, Ohio. , “I am ... will feature hundreds of adoptable pets from more than forty ...
Breaking Medicine News(10 mins):Health News:Array Health’s Senior Director of Marketing to Present at The Fourth Annual Direct-to-Consumer Health Care Marketing Summit 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 3Health News:Prominent Doctors with Distinguished Backgrounds Join Doctors on Liens in Tujunga 2Health News:Guiding Principles for Patient Experience Excellence Identified by The Beryl Institute 2Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2
... prevalence of leprosy is decreasing to about 0.95 cases per ... is eliminated from India. // But this statement is very ... completely eliminated but the prevalence is significantly reduced. It is ... 10,000 population. ,In India Delhi has a high ...
... feel good when they are complimented on their age. It is ... // life with loads of money minus the worries. It is ... and drink heavily. ,This study mainly aims in understanding ... on the way men and women age. It is very astonishing ...
... number of dentists who graduate from the dental schools stay in ... rise and the health officials fear that his is due to ... ,Many dental graduates are out of job due to this ... the dental graduates who left Scotland to find work elsewhere but ...
... that consumption of fish oil can counteract the effect of ... health. // The results of the present study have valuable ... ,The study participants were required to consume a ... months. Those who consumed soy oil supplements formed the control ...
... potential of stem cells in the repair and treatment ... stem cells from muscle tissue // of injured rats ... a therapeutic protein (bone morphogenetic protein 4, BMP-4, capable ... a repair mechanism can be instituted in humans as ...
... based Vancouver Company Copeman Healthcare Inc.’s may face charges ... to charge an initial consultation fee of $3,500. // ... memorandum to the Health ministry to take action against ... based treatment and recommends universal rate for all treatment. ...
Cached Medicine News:Health News:Lifestyle plays an important role in determining one’s ag 2Health News:Shortage of dentists in Scotland 2Health News:Muscle Derived Stem Cell Can Repair Damaged Cartilage 2
Radianse indoor positioning supports healthcare asset management with a way to locate medical equipment, devices and other portable assets....
Agility has delivered a RFID-enabled mobile asset management program....
Agility can provide tracking and management of surgical instruments, instrument trays and case carts to significantly enhance the current central sterile department flow by improving efficiency....
Assetrac allows identification, location, and protection of your assets....
Medicine Products: